BioAscent is attending the 10th RSC-BMCS Fragment-based Drug Discovery Meeting on 14-16 September at Churchill College, Cambridge.

The aim of the 10th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late-stage medicinal chemistry, preclinical or clinical programmes.

The BioAscent team will be available to meet event delegates. If you’d like to arrange a meeting, please get in touch by emailing info@bioascent.com.

Find out more about the meeting here.